Omalizumab in Children with Severe Allergic Asthma: The Italian Real- Life Experience

By  

Current Respiratory Medicine Reviews, Vol. 13, Iss. 1, 2017-10 ,pp. : 36-42

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Omalizumab as Add-On Therapy on Asthma-Related Quality of Life in Severe Allergic Asthma: A Brazilian Study (QUALITX)

By Rubin A.S   Souza-Machado A.   Andradre-Lima M.   Ferreira F.   Honda A.   Matozo T.M.  

Journal of Asthma, Vol. 49, Iss. 3, 2012-04 ,pp. : 288-293

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness and Safety of Dabigatran and Warfarin in Real‐World US Patients With Non‐Valvular Atrial Fibrillation: A Retrospective Cohort Study

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 4, 2015-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessment of Long-term Omalizumab Treatment in Patients with Severe Allergic Asthma Long-term Omalizumab Treatment in Severe Asthma

By Özgür Eylem Sercan   Özge Cengiz   Ïlvan Ahmet   Naycı Sibel Atış  

Journal of Asthma, Vol. 50, Iss. 6, 2013-08 ,pp. : 687-694

Informa Healthcare

Access to resources Recommend Favorite

Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab)

By D'Amato Gennaro  

Treatments in Respiratory Medicine, Vol. 5, Iss. 6, 2006-01 ,pp. : 393-398

Adis International

Access to resources Recommend Favorite